Dr. Juan Pablo Alderuccio, MD

  • Miami, FL
  • Hematologist and oncologist
NPI1639502123PAC ID0143588343
Medicare services, 2024
266
Medicare patients, 2024
105
Part D claims, 2024
298
Publications
72
Clinical trials
3
Practice address
1475 Nw 12th Ave, Miami, FL 33136
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Sylvester Comprehensive Cancer Center

Hospital · Miami, Florida

Find Dr. Alderuccio's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Juan Pablo Alderuccio is a hematologist and oncologist in Miami, Florida

Dr. Alderuccio practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Dr. Alderuccio's NPI, 1639502123, was assigned on August 20, 2013. Dr. Alderuccio holds Florida license ME131937.

NPI and contact details
Medicare PAC ID
0143588343
NPI enumeration date
August 20, 2013
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
49
Medical school graduation
2003

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Juan Pablo Alderuccio practices at Sylvester Comprehensive Cancer Center in Miami, Florida

Dr. Alderuccio's primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Source: Dmand AI Affiliation Data

Dr. Juan Pablo Alderuccio is affiliated with 2 sites of care and 1 medical group

Dr. Alderuccio's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. Dr. Alderuccio is also affiliated with Jackson Memorial Hospital. The medical group on file is University of Miami Health System.

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Juan Pablo Alderuccio's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Alderuccio practices, 2 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Sylvester Comprehensive Cancer CenterAvailable with a free account
+1 more affiliated siteAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Alderuccio practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across University of Miami and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Juan Pablo Alderuccio is one of 693 hematologists and oncologists in Florida

Hematology and oncology is Dr. Alderuccio's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Alderuccio is board certified in hematology by the American Board of Internal Medicine. Dr. Alderuccio is licensed in Florida.

Specialties and state licenses

  • Hematology and oncology, FloridaPrimaryLicense ME131937 · 2017 to 2027 · taxonomy 207RH0003X

Hematologists and oncologists near Dr. Alderuccio

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Juan Pablo Alderuccio billed Medicare for 266 services in 2024

CMS data shows 266 Medicare services from Dr. Alderuccio across 5 procedure codes in 2024, for 105 Medicare patients. Medicare paid $23,863 for them. Every service was in a facility, such as a hospital, rather than an office.

Medicare services, 2024266
Medicare patients105
Paid by Medicare$23,863
Procedure codes5

Dr. Alderuccio's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 3232024: 26618%

Dr. Alderuccio compared with the Florida median for hematologists and oncologists, 2024

  • Dr. Alderuccio
  • Florida median
Medicare services
266vs 69762% below
Medicare patients
105vs 21852% below
Part D claims
238vs 34130% below

Medians across 638 hematologists and oncologists in Florida with Dmand AI profiles that report each measure.

Dr. Alderuccio's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Alderuccio

Need commercial claims for Dr. Alderuccio?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Alderuccio and other hematologists and oncologists in Florida.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Juan Pablo Alderuccio treated 105 Medicare patients in 2024, average age 73

CMS counts 105 Medicare patients who saw Dr. Alderuccio in 2024. The largest group is 75 to 84, with 50 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 23% are also on Medicaid. Their average risk score is 2.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Alderuccio's median patient age at 72, with 53% women.

Medicare patients, 2024105
Average age73
Average risk score2.53
Also on Medicaid23%

Dr. Alderuccio's Medicare patients by age, 2024

CMS leaves out age groups with fewer than 11 patients.

Dr. Alderuccio's Medicare patients by sex, 2024

  • Women4442%
  • Men6158%

Chronic conditions among Dr. Alderuccio's Medicare patients, 2024

  1. High cholesterol75%
  2. High blood pressure71%
  3. Chronic kidney disease39%
  4. Arthritis38%
  5. Ischemic heart disease34%
  6. Diabetes31%
  7. Mood disorders30%
  8. Anxiety25%

Share of Medicare patients with each condition. A patient can have several.

Dr. Alderuccio's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 72

Patient panel by sex, all payers

  • Women53%
  • Men47%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Juan Pablo Alderuccio wrote 298 Medicare Part D claims in 2024

In 2024, Dr. Alderuccio wrote 298 Medicare Part D claims for 43 patients. 71% of them were for generic drugs. CMS names the drug for 238 of them, across 10 drugs with 11 or more claims each, at $1,283,221 in total drug cost. In 2023, CMS named 294 claims across 10 drugs.

Part D claims, 2024298
Drugs named by CMS10
Total drug cost$1.3M
Part D patients43

Dr. Alderuccio's Part D claims by kind of drug, 2024

  • Generic213 claims71%
  • Brand-name85 claims29%

Dr. Alderuccio's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Alderuccio's Part D claims, 2024

  • Antibiotics8%25 of 298 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 2942024: 23819%

Drugs named by CMS: 10 in 2024, 10 in 2023.

See all prescribing by Dr. Alderuccio

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Juan Pablo Alderuccio scored 88 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Alderuccio for performance year 2024, reported as part of a group. Dr. Alderuccio accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Alderuccio as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Dr. Alderuccio's MIPS scores, performance year 2024

  • 88of 100Final score
  • 78.8of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities
  • 71of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Alderuccio by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Juan Pablo Alderuccio has 72 publications on record

Dmand AI links 72 papers to Dr. Alderuccio, published from 2013 to 2025. 2021 was the busiest year, with 12. The most frequent topics are Lymphoma, B-Cell, Marginal Zone, Lymphoma, Large B-Cell, Diffuse and Antineoplastic Combined Chemotherapy Protocols. Dr. Alderuccio has published most often in Blood Adv. Dr. Alderuccio's most frequent co-authors are Izidore Lossos, MD, Paolo F. Caimi, MD and Brad Steven Kahl, MD.

Papers72
Years published2013 to 2025

Dr. Alderuccio's papers by year, 2016 to 2025

Topics Dr. Alderuccio writes about most

  • Lymphoma, B-Cell, Marginal Zone
  • Lymphoma, Large B-Cell, Diffuse
  • Antineoplastic Combined Chemotherapy Protocols
  • Antibodies, Monoclonal, Humanized
  • Benzodiazepines
  • Lymphoma, Follicular
  • Positron Emission Tomography Computed Tomography
  • Cell Transformation, Neoplastic

Dr. Alderuccio's most frequent co-authors

Recent publications by Dr. Alderuccio

See all 72 publications and co-authors

See who Dr. Alderuccio researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Alderuccio works with, so you can find a warm path to the right hematologists and oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Juan Pablo Alderuccio has worked on 3 clinical trials

Dmand AI links Dr. Alderuccio to 3 clinical trials, 2 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Lymphoma, B-Cell, Marginal Zone, Lymphoma, Follicular and Lymphoma, Large B-Cell, Diffuse.

Clinical trials with Dr. Alderuccio by phase

  1. NonePhase 1: no trials
  2. 2Phase 2: 2 trials
  3. 1Phase 2/3: 1 trial
  4. NonePhase 3: no trials
  5. NonePhase 4: no trials

Conditions in Dr. Alderuccio's trials

  • Lymphoma, B-Cell, Marginal Zone
  • Lymphoma, Follicular
  • Lymphoma, Large B-Cell, Diffuse
  • Lymphoma, Non-Hodgkin

Investigators on the most trials with Dr. Alderuccio

Recent clinical trials with Dr. Alderuccio

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Juan Pablo Alderuccio received $50,498 in industry payments from 2016 to 2025

CMS Open Payments shows 321 general payments to Dr. Alderuccio from 26 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 70% of the total. ADC Therapeutics America, Inc. paid the most, $14,679.

General payments to Dr. Alderuccio by program year, 2016 to 2025

General payments to Dr. Alderuccio by kind, 2016 to 2025

$50.5Kin total
  • Consulting fees$35,13270%
  • Food and beverage$7,69315%
  • Travel and lodging$4,80410%
  • Honoraria$2,4005%
  • Other$4691%

Companies that paid Dr. Alderuccio the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Alderuccio

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Juan Pablo Alderuccio has 3 awards and honors on record

Dmand AI lists 3 awards for Dr. Alderuccio, most recently Clinical Investigator Career Development Award in 2022. Dr. Alderuccio serves on Protocol Review and Monitoring Committee and American Society of Hematology Committee on Educational Affairs.

Awards and honors for Dr. Alderuccio

  1. 2022
    • Clinical Investigator Career Development Award
    • FDA-AACR Oncology Educational Fellowship
  2. 2021
    • K12 Calabresi Clinical Oncology Research Career Development Award

Dr. Alderuccio's committees and leadership roles

Protocol Review and Monitoring CommitteeMember
2021 to present

Source: Dmand AI Professional Profile Data

Dr. Juan Pablo Alderuccio is board certified in hematology

Dr. Alderuccio is a member of ASCO and ASH.

  1. Board certified in hematologyAmerican Board of Internal Medicine
  2. Board certified in medical oncologyAmerican Board of Internal Medicine

Source: Dmand AI Professional Profile Data

Dr. Juan Pablo Alderuccio accepts plans from 10 insurance carriers

Dr. Alderuccio is in network with 10 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 6. Check the plan with the practice before a visit.

  • Aetna
  • Elevance
  • United Healthcare
  • Molina
  • Aspirus Health Plan
  • Blue Cross and Blue Shield of Kansas City
  • Blue Cross Blue Shield of Michigan
  • CMS Medicare
  • +2 more carriersWith a free account

Plan types Dr. Alderuccio accepts, by number of carriers

  1. PPO6
  2. Medicare5
  3. HMO4
  4. POS4
  5. EPO3

Source: Dmand AI Insurance Network Data

Sources for Dr. Juan Pablo Alderuccio's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Awards and committee rolesDmand AI Professional Profile Data
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Juan Pablo Alderuccio

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Juan Pablo Alderuccio's NPI number?

Dr. Juan Pablo Alderuccio's NPI number is 1639502123. It was assigned on August 20, 2013, and it is active in the NPI Registry.

What kind of doctor is Dr. Juan Pablo Alderuccio?

Dr. Juan Pablo Alderuccio is a hematologist and oncologist in Miami, Florida. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. Juan Pablo Alderuccio practice?

Dr. Alderuccio practices at 1475 Nw 12th Ave, Miami, FL 33136. Dr. Alderuccio's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

What is Dr. Juan Pablo Alderuccio's medical license number?

Dr. Alderuccio holds Florida license ME131937.

Which hospitals is Dr. Juan Pablo Alderuccio affiliated with?

Dr. Alderuccio practices at Sylvester Comprehensive Cancer Center in Miami, Florida. Dr. Alderuccio is also affiliated with Jackson Memorial Hospital.

What medical group is Dr. Juan Pablo Alderuccio part of?

Dr. Alderuccio is linked to University of Miami Health System.

Does Dr. Juan Pablo Alderuccio accept Medicare?

Yes. CMS data shows Dr. Alderuccio billed Medicare for 266 services in 2024, and Dr. Alderuccio accepts Medicare assignment.

Does Dr. Juan Pablo Alderuccio offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Alderuccio as offering telehealth services.

What is Dr. Juan Pablo Alderuccio's MIPS score?

Dr. Alderuccio's MIPS final score for performance year 2024 is 88 out of 100, reported as part of a group.

How many Medicare patients does Dr. Juan Pablo Alderuccio see?

CMS counts 105 Medicare patients who saw Dr. Alderuccio in 2024, with an average age of 73.

Show 8 more questionsShow fewer questions

Is Dr. Juan Pablo Alderuccio board certified?

Yes. Dr. Alderuccio is board certified in hematology by the American Board of Internal Medicine.

What services does Dr. Juan Pablo Alderuccio bill to Medicare?

In 2024, Dr. Alderuccio's most billed Medicare services were office visit, established patient (99214), hospital inpatient care (99233) and office visit, established patient (99215).

What drugs does Dr. Juan Pablo Alderuccio prescribe most?

In 2024 Medicare Part D data, Dr. Alderuccio's most prescribed drugs by claims were Acyclovir, Entecavir and Prednisone.

Has Dr. Juan Pablo Alderuccio received payments from drug or device companies?

CMS Open Payments shows $50,498 in general payments to Dr. Alderuccio from 26 companies from 2016 to 2025. The largest total came from ADC Therapeutics America, Inc.

How long has Dr. Juan Pablo Alderuccio been practicing?

Dr. Alderuccio graduated from medical school in 2003, 23 years ago.

Does Dr. Juan Pablo Alderuccio do research?

Dmand AI links 72 publications to Dr. Alderuccio, published from 2013 to 2025. Dr. Alderuccio has worked on 3 clinical trials.

Who does Dr. Juan Pablo Alderuccio publish with?

Dr. Alderuccio's most frequent co-authors are Izidore Lossos, MD (49 shared papers), Paolo F. Caimi, MD (12 shared papers) and Brad Steven Kahl, MD (12 shared papers).

What insurance does Dr. Juan Pablo Alderuccio accept?

Dr. Alderuccio is in network with 10 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 6. Check the plan with the practice before a visit.

Selling to hematology and oncology practices?

See hematologists and oncologists in Florida by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)